Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00795756Phase 3Completed
A Phase 3 trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), sponsored by Northern Italy Leukemia Group. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00795756.